These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 2045716)

  • 1. Dipyridamole binding to proteins in human plasma and tissue culture media.
    Szebeni J; Weinstein JN
    J Lab Clin Med; 1991 Jun; 117(6):485-92. PubMed ID: 2045716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of intraperitoneally administered dipyridamole in cancer patients.
    Chan TC; Coppoc GL; Zimm S; Cleary S; Howell SB
    Cancer Res; 1988 Jan; 48(1):215-8. PubMed ID: 3334996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transsynovial kinetics of lonazolac and its hydroxy metabolite in synovitis patients.
    Deneke J; Luckow V; Guserle R; Pässler HH
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):418-24. PubMed ID: 9726694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective serum protein binding of mexiletine enantiomers in man.
    McErlane KM; Igwemezie L; Kerr CR
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):141-4. PubMed ID: 3589151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of human plasma protein binding of baicalin by ultrafiltration and high-performance liquid chromatography.
    Tang Y; Zhu H; Zhang Y; Huang C
    Biomed Chromatogr; 2006 Oct; 20(10):1116-9. PubMed ID: 16708379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The determination of free and protein-bound haemoglobin in plasma using a combination of HPLC and absorption spectrometry.
    Wood WG; Kress M; Meissner D; Hanke R; Reinauer H
    Clin Lab; 2001; 47(5-6):279-88. PubMed ID: 11405606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I trial of dipyridamole with 5-fluorouracil and folinic acid.
    Budd GT; Jayaraj A; Grabowski D; Adelstein D; Bauer L; Boyett J; Bukowski R; Murthy S; Weick J
    Cancer Res; 1990 Nov; 50(22):7206-11. PubMed ID: 2224854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of selected drugs on the in vitro protein binding of repaglinide in human plasma.
    Plum A; Müller LK; Jansen JA
    Methods Find Exp Clin Pharmacol; 2000 Apr; 22(3):139-43. PubMed ID: 10893694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of free and liposome-associated doxorubicin and vincristine levels in plasma under equilibrium conditions employing ultrafiltration techniques.
    Mayer LD; St-Onge G
    Anal Biochem; 1995 Dec; 232(2):149-57. PubMed ID: 8747469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of unbound drug concentration and protein-drug binding fraction in plasma.
    Liu Z; Li F; Huang Y
    Biomed Chromatogr; 1999 Jun; 13(4):262-6. PubMed ID: 10416057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory action of ganglioside GM3 on murine neuroblastoma cell proliferation: modulating effect of fetal calf serum.
    Zhang C; Paller AS; Mirkin BL
    Anticancer Res; 1995; 15(3):661-6. PubMed ID: 7645939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical assessment of the effects of acivicin and dipyridamole given as a continuous 72-hour intravenous infusion.
    Fischer PH; Willson JK; Risueno C; Tutsch K; Bruggink J; Ranhosky A; Trump DL
    Cancer Res; 1988 Oct; 48(19):5591-6. PubMed ID: 3416312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myocardial microcirculation in humans--new approaches using MRI].
    Wacker CM; Bauer WR
    Herz; 2003 Mar; 28(2):74-81. PubMed ID: 12669220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics of cyclosporine. II. Blood plasma distribution and binding studies.
    Awni WM; Sawchuk RJ
    Drug Metab Dispos; 1985; 13(2):133-8. PubMed ID: 2859158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The determination of total and unbound midazolam in human plasma. A comparison of high performance liquid chromatography, gas chromatography and gas chromatography/mass spectrometry.
    de Vries JX; Rudi J; Walter-Sack I; Conradi R
    Biomed Chromatogr; 1990 Jan; 4(1):28-33. PubMed ID: 2310839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea, a novel agent equally cytotoxic to nonproliferating human colon adenocarcinoma cells.
    Houghton PJ; Bailey FC; Germain GS; Grindey GB; Witt BC; Houghton JA
    Cancer Res; 1990 Jan; 50(2):318-22. PubMed ID: 2295071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective binding of isradipine to human plasma proteins.
    Oravcová J; Sojková D; Bencsíková E; Bohov P; Trnovec T
    Chirality; 1995; 7(3):167-72. PubMed ID: 7794694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partitioning of thioridazine and mesoridazine in human blood fractions.
    Dinovo EC; Pollak H; Gottschalk LA
    Methods Find Exp Clin Pharmacol; 1984 Mar; 6(3):143-6. PubMed ID: 6748818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theophylline binding to plasma proteins in patients with chronic obstructive pulmonary disease.
    Calandre EP; Pérez de la Cruz A; Alferez NP; Moreno Carretero E; Hinojosa R; Vázquez Mata G
    Int J Clin Pharmacol Res; 1986; 6(5):397-401. PubMed ID: 3781702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
    Kiriyama A; Nishiura T; Ishino M; Yamamoto Y; Ogita I; Kiso Y; Takada K
    Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.